Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from June 9, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on September 7, 2026 — +13.8% at the close.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$40.96 Published $44.48 Target $46.60 Window close $51.46 Peak
$39.00 – $40.95Entry zone — fair-value band
$40.96Published — price the day we called it
$44.48Target — the price the thesis aimed for
$51.46Peak — highest point inside the window, not a realized return
$46.60Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 13 days.

At window close
+13.8%
realized, from the publication price to the last close inside the window
Peak gain
+25.7%
peak, from the publication price — not a realized return
S&P 500, same window
+4.8%
SPY over the identical days, dividend-adjusted
Window close
$46.60
last close inside the window, ended September 7, 2026
Peak price
$51.46
peak on July 29, 2026 — not a realized return
Days to target
13

The thesis — published June 9, 2026

Predicted growth
+10%
over the measurement window
Target price
$44.48
the price the thesis aimed for
Entry zone
$39.00 – $40.95
the fair-value band we waited for
Price at publication
$40.96
published June 9, 2026
Confidence
80%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novo Nordisk is a steady healthcare name that can hold up when markets are choppy. A new version of Rybelsus in Canada shows the company is keeping its product plans on track, and demand for diabetes and obesity treatments remains strong. The stock looks reasonably priced for its profit margins, but a recent earnings shortfall and debt levels make the short-term outlook cautious rather than aggressive.

Primary drivers

  • New Rybelsus version in Canada keeps product plans moving
  • Ongoing strong demand for diabetes and obesity drugs
  • Lower-risk healthcare exposure helps in volatile markets
  • Reasonable price versus high margins helps limit downside

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All NVO signals